Researchers at the Leiden University Medical Center (Netherlands) and collaborators developed a tumor-specific fluorescent agent and imaging system that could guide surgeons in real time to remove additional tumors in ovarian cancer patients that were not visible without fluorescence or could not be felt during surgery.